Cornerstone Planning’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cornerstone Planning's LLY Position: Q3 2026 in Review
Cornerstone Planning increased its Eli Lilly (LLY) stake by 0.36% in Q3 2026, buying an estimated $16.5K and bringing the position to 3,875 shares worth $4.61M. The position accounts for 0.95% of the portfolio, ranked #34.
Cornerstone Planning first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.63M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Cornerstone Planning held 3,875 shares of Eli Lilly worth $4.61M as of Q3 2026.
- Cornerstone Planning bought 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
- Eli Lilly made up 0.95% of Cornerstone Planning's portfolio in Q3 2026, its #34 holding.
- Cornerstone Planning first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
- Cornerstone Planning's Eli Lilly position peaked at $4.63M in Q2 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Cornerstone Planning's 13F filing for Q3 2026, filed 27 Oct 2026.